US hair loss technology provider Kerastem has confirmed that patients who underwent the Phase 2 clinical trial in early-stage hair loss achieved an increase in mean terminal hair count in men with early hair loss when compared to the control group. Based on these results, Kerastem plans to begin a Phase 3 clinical trial later this year.
Global skincare company Obagi Medical has launched a worldwide initiative that is designed to celebrate diversity, titled SKINCLUSION.
A non-surgical, non-permanent gastric balloon that is designed to suppress appetite and teach portion control has now been launched into the UK aesthetic market, called the Elipse.
In August last year high street retailer Superdrug announced that it would be offering a Skin Renew Service featuring botulinum toxin and filler treatments to customers in its London Strand store.
Skincare company PCA Skin has added a new skin brightening product to its portfolio, called the Enzymatic Treatment.
Pharmaceutical and skincare manufacturer mesoestetic has released a treatment protocol, called global eyecon, that aims to correct wrinkles and expression lines in the periocular area, under-eye bags, dark circles and drooping under the eyelid.
UK and Ireland distributor of IBSA Italia, HA-Derma, invited guests to travel to Milan, Italy for two days of learning on February 14 and 15.
Aesthetic Technology Ltd, manufacturer of the Dermalux LED systems, has launched two new products; the Tri-Wave MD and the Flex.
Aesthetic practitioner Dr David Jack will outline the benefits of combining IPL and bipolar radiofrequency for total skin rejuvenation in a free educational session at the Aesthetics Conference and Exhibition (ACE) on Friday March 1.
Pharmaceutical company Sinclair Pharma has introduced the Ultimate Reshaping Solution, a set of four new protocols, titled the Recontour, Redefine, Reshape and Reshape Plus.